Biotechnology
Compare Stocks
5 / 10Stock Comparison
TLX vs LNTH vs RNW vs AGEN vs GE
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
Renewable Utilities
Biotechnology
Aerospace & Defense
TLX vs LNTH vs RNW vs AGEN vs GE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic | Renewable Utilities | Biotechnology | Aerospace & Defense |
| Market Cap | $3.57B | $6.06B | $1.38B | $135M | $310.47B |
| Revenue (TTM) | $1.66B | $1.55B | $129.66B | $114M | $48.35B |
| Net Income (TTM) | $66M | $279M | $11.97B | $115K | $8.66B |
| Gross Margin | 61.6% | 60.5% | 77.9% | 35.7% | 34.8% |
| Operating Margin | 7.1% | 18.8% | 48.4% | -17.7% | 18.5% |
| Forward P/E | 167.1x | 17.7x | 0.4x | 2.9x | 39.3x |
| Total Debt | $581M | $738K | $732.28B | $10M | $20.49B |
| Cash & Equiv. | $710M | $359M | $40.42B | $3M | $12.39B |
TLX vs LNTH vs RNW vs AGEN vs GE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | May 26 | Return |
|---|---|---|---|
| Telix Pharmaceutica… (TLX) | 100 | 64.8 | -35.2% |
| Lantheus Holdings, … (LNTH) | 100 | 104.2 | +4.2% |
| ReNew Energy Global… (RNW) | 100 | 93.2 | -6.8% |
| Agenus Inc. (AGEN) | 100 | 111.7 | +11.7% |
| GE Aerospace (GE) | 100 | 163.1 | +63.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TLX vs LNTH vs RNW vs AGEN vs GE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TLX ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.88
- Rev growth 55.8%, EPS growth 7.7%, 3Y rev CAGR 368.9%
- 55.8% revenue growth vs LNTH's 0.5%
LNTH carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 42.9% 10Y total return vs GE's 117.1%
- Lower volatility, beta 0.45, Low D/E 0.1%, current ratio 2.70x
- Beta 0.45, current ratio 2.70x
- 18.0% margin vs AGEN's 0.1%
RNW is the clearest fit if your priority is value.
- Lower P/E (0.4x vs 39.3x)
Among these 5 stocks, AGEN doesn't own a clear edge in any measured category.
GE is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 0.5% yield; 2-year raise streak; the other 4 pay no meaningful dividend
- +39.3% vs TLX's -37.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 55.8% revenue growth vs LNTH's 0.5% | |
| Value | Lower P/E (0.4x vs 39.3x) | |
| Quality / Margins | 18.0% margin vs AGEN's 0.1% | |
| Stability / Safety | Beta 0.45 vs AGEN's 2.58 | |
| Dividends | 0.5% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +39.3% vs TLX's -37.4% | |
| Efficiency (ROA) | 12.4% ROA vs AGEN's 0.1% |
TLX vs LNTH vs RNW vs AGEN vs GE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TLX vs LNTH vs RNW vs AGEN vs GE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RNW leads in 2 of 6 categories
LNTH leads 2 • GE leads 2 • TLX leads 0 • AGEN leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
RNW leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RNW is the larger business by revenue, generating $129.7B annually — 1135.4x AGEN's $114M. LNTH is the more profitable business, keeping 18.0% of every revenue dollar as net income compared to AGEN's 0.1%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $1.5B | $129.7B | $114M | $48.4B |
| EBITDAEarnings before interest/tax | $132M | $347M | $86.9B | -$10M | $9.9B |
| Net IncomeAfter-tax profit | $66M | $279M | $12.0B | $115,000 | $8.7B |
| Free Cash FlowCash after capex | $45M | $372M | -$23.8B | -$159M | $7.5B |
| Gross MarginGross profit ÷ Revenue | +61.6% | +60.5% | +77.9% | +35.7% | +34.8% |
| Operating MarginEBIT ÷ Revenue | +7.1% | +18.8% | +48.4% | -17.7% | +18.5% |
| Net MarginNet income ÷ Revenue | +4.0% | +18.0% | +9.2% | +0.1% | +17.9% |
| FCF MarginFCF ÷ Revenue | +2.7% | +24.0% | -18.4% | -139.1% | +15.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.1% | +1.2% | +37.2% | +27.5% | +24.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -130.9% | +76.5% | +94.8% | +85.3% | -1.1% |
Valuation Metrics
RNW leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 27.3x trailing earnings, LNTH trades at a 74% valuation discount to TLX's 105.7x P/E. On an enterprise value basis, RNW's 11.3x EV/EBITDA is more attractive than TLX's 54.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.6B | $6.1B | $1.4B | $135M | $310.5B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $5.7B | $8.7B | $142M | $318.6B |
| Trailing P/EPrice ÷ TTM EPS | 105.68x | 27.29x | 48.63x | -1123.53x | 36.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 167.14x | 17.70x | 0.41x | 2.94x | 39.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 3.08x |
| EV / EBITDAEnterprise value multiple | 54.93x | 14.96x | 11.33x | — | 31.89x |
| Price / SalesMarket cap ÷ Revenue | 6.32x | 3.93x | 1.35x | 1.18x | 6.77x |
| Price / BookPrice ÷ Book value/share | 8.99x | 5.84x | 1.48x | — | 16.78x |
| Price / FCFMarket cap ÷ FCF | 172.51x | 17.11x | — | — | 42.74x |
Profitability & Efficiency
LNTH leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
GE delivers a 45.8% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $8 for RNW. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to RNW's 5.59x. On the Piotroski fundamental quality scale (0–9), AGEN scores 6/9 vs RNW's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.6% | +24.3% | +8.4% | — | +45.8% |
| ROA (TTM)Return on assets | +5.5% | +12.4% | +1.2% | +0.1% | +6.8% |
| ROICReturn on invested capital | +25.5% | +30.6% | +4.9% | — | +24.7% |
| ROCEReturn on capital employed | +11.5% | +17.1% | +6.9% | — | +9.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 4 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.02x | 0.00x | 5.59x | — | 1.08x |
| Net DebtTotal debt minus cash | -$129M | -$358M | $691.9B | $7M | $8.1B |
| Cash & Equiv.Liquid assets | $710M | $359M | $40.4B | $3M | $12.4B |
| Total DebtShort + long-term debt | $581M | $738,000 | $732.3B | $10M | $20.5B |
| Interest CoverageEBIT ÷ Interest expense | 4.31x | 15.83x | 86.76x | 1.11x | 11.69x |
Total Returns (Dividends Reinvested)
GE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GE five years ago would be worth $45,251 today (with dividends reinvested), compared to $635 for AGEN. Over the past 12 months, GE leads with a +39.3% total return vs TLX's -37.4%. The 3-year compound annual growth rate (CAGR) favors GE at 55.1% vs AGEN's -50.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +40.2% | +38.3% | -4.1% | +18.3% | -7.2% |
| 1-Year ReturnPast 12 months | -37.4% | +15.7% | -12.7% | +25.7% | +39.3% |
| 3-Year ReturnCumulative with dividends | -29.5% | -1.9% | +8.7% | -88.0% | +273.2% |
| 5-Year ReturnCumulative with dividends | -29.5% | +338.1% | -43.3% | -93.7% | +352.5% |
| 10-Year ReturnCumulative with dividends | -29.5% | +4289.6% | -48.5% | -94.2% | +117.1% |
| CAGR (3Y)Annualised 3-year return | -11.0% | -0.6% | +2.8% | -50.7% | +55.1% |
Risk & Volatility
LNTH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LNTH is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than AGEN's 2.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 98.1% from its 52-week high vs AGEN's 52.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.88x | 0.45x | 0.69x | 2.58x | 1.19x |
| 52-Week HighHighest price in past year | $18.49 | $94.86 | $8.24 | $7.34 | $348.48 |
| 52-Week LowLowest price in past year | $6.30 | $47.25 | $4.38 | $2.71 | $210.51 |
| % of 52W HighCurrent price vs 52-week peak | +57.8% | +98.1% | +68.2% | +52.0% | +85.3% |
| RSI (14)Momentum oscillator 0–100 | 56.3 | 69.9 | 61.3 | 46.1 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 230K | 872K | 739K | 822K | 5.7M |
Analyst Outlook
GE leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: TLX as "Buy", LNTH as "Buy", RNW as "Buy", AGEN as "Buy", GE as "Buy". Consensus price targets imply 91.9% upside for AGEN (target: $7) vs 6.7% for LNTH (target: $99). GE is the only dividend payer here at 0.46% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $17.00 | $99.25 | $6.52 | $7.33 | $386.20 |
| # AnalystsCovering analysts | 5 | 17 | 6 | 11 | 34 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.5% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 1 | 1 | 2 |
| Dividend / ShareAnnual DPS | — | — | — | — | $1.36 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.0% | 0.0% | +0.1% | +2.4% |
RNW leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). LNTH leads in 2 (Profitability & Efficiency, Risk & Volatility).
TLX vs LNTH vs RNW vs AGEN vs GE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TLX or LNTH or RNW or AGEN or GE a better buy right now?
For growth investors, Telix Pharmaceuticals Limited (TLX) is the stronger pick with 55.
8% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 27. 3x trailing P/E (17. 7x forward), making it the more compelling value choice. Analysts rate Telix Pharmaceuticals Limited (TLX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TLX or LNTH or RNW or AGEN or GE?
On trailing P/E, Lantheus Holdings, Inc.
(LNTH) is the cheapest at 27. 3x versus Telix Pharmaceuticals Limited at 105. 7x. On forward P/E, ReNew Energy Global Plc is actually cheaper at 0. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — TLX or LNTH or RNW or AGEN or GE?
Over the past 5 years, GE Aerospace (GE) delivered a total return of +352.
5%, compared to -93. 7% for Agenus Inc. (AGEN). Over 10 years, the gap is even starker: LNTH returned +42. 9% versus AGEN's -94. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TLX or LNTH or RNW or AGEN or GE?
By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.
(LNTH) is the lower-risk stock at 0. 45β versus Agenus Inc. 's 2. 58β — meaning AGEN is approximately 468% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 6% for ReNew Energy Global Plc — giving it more financial flexibility in a downturn.
05Which is growing faster — TLX or LNTH or RNW or AGEN or GE?
By revenue growth (latest reported year), Telix Pharmaceuticals Limited (TLX) is pulling ahead at 55.
8% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Telix Pharmaceuticals Limited grew EPS 769. 6% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, TLX leads at 368. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TLX or LNTH or RNW or AGEN or GE?
GE Aerospace (GE) is the more profitable company, earning 19.
0% net margin versus 0. 1% for Agenus Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RNW leads at 53. 5% versus -18. 0% for AGEN. At the gross margin level — before operating expenses — RNW leads at 91. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TLX or LNTH or RNW or AGEN or GE more undervalued right now?
On forward earnings alone, ReNew Energy Global Plc (RNW) trades at 0.
4x forward P/E versus 167. 1x for Telix Pharmaceuticals Limited — 166. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AGEN: 91. 9% to $7. 33.
08Which pays a better dividend — TLX or LNTH or RNW or AGEN or GE?
In this comparison, GE (0.
5% yield) pays a dividend. TLX, LNTH, RNW, AGEN do not pay a meaningful dividend and should not be held primarily for income.
09Is TLX or LNTH or RNW or AGEN or GE better for a retirement portfolio?
For long-horizon retirement investors, Lantheus Holdings, Inc.
(LNTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45)). Agenus Inc. (AGEN) carries a higher beta of 2. 58 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LNTH: +42. 9%, AGEN: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TLX and LNTH and RNW and AGEN and GE?
These companies operate in different sectors (TLX (Healthcare) and LNTH (Healthcare) and RNW (Utilities) and AGEN (Healthcare) and GE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TLX is a small-cap high-growth stock; LNTH is a small-cap quality compounder stock; RNW is a small-cap high-growth stock; AGEN is a small-cap quality compounder stock; GE is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.